Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors

Overview of attention for article published in Journal for Immunotherapy of Cancer, May 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 1 X user

patent: 4 patents

Citations

dimensions_citation: 62 Dimensions

Readers on

mendeley: 85 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

TOLL-LIKE RECEPTOR 7 OR 8 AGONIST AND CHOLESTEROL COMPLEX AND ITS USE

N/A RU-2790702-C1

Russian Federation

ANTIGEN-AGNOSTIC COMBINATION IMMUNOTHERAPY

Application WO-2023021065-A1

World Intellectual Property Organisation (WIPO)

HUMAN METAPNEUMO VIRUS VACCINE

Application WO-2022214678-A2

World Intellectual Property Organisation (WIPO)

METHODS AND COMPOSITIONS FOR TREATING PRECANCEROUS LESIONS OR CANCER COMPRISING TLR/TLR…

Application WO-2018060513-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.